Introduction
Pharmaceutical GMP audits often identify similar findings across organizations. This blog describes 10 common findings and how to prevent them. It also explains how GxP Cellators supports organizations through the audit process.
Common Finding 1: Data Integrity Issues
Data integrity issues include shared accounts, disabled audit trails, and incomplete records.
How to Prevent:
- Enable audit trails for all GxP systems
- Eliminate shared accounts
- Implement access controls
- Train personnel on data integrity
Common Finding 2: Incomplete Documentation
Documentation gaps include incomplete batch records, missing signatures, and undocumented changes.
How to Prevent:
- Review documentation procedures
- Train personnel on documentation requirements
- Implement review processes
- Conduct regular documentation audits
Common Finding 3: Inadequate Deviation Investigation
Deviation investigations are often superficial.
How to Prevent:
- Improve root cause analysis training
- Implement CAPA effectiveness checks
- Track deviation trends
- Review investigation quality
Common Finding 4: Ineffective CAPA
CAPAs are often not effective.
How to Prevent:
- Conduct root cause analysis
- Develop specific corrective actions
- Verify effectiveness
- Track CAPA metrics
Common Finding 5: Inadequate Training
Training gaps include outdated records and inadequate GMP training.
How to Prevent:
- Maintain current training records
- Conduct regular GMP training
- Assess training effectiveness
- Document all training
Common Finding 6: Equipment Calibration Issues
Calibration issues include overdue calibrations and incomplete records.
How to Prevent:
- Maintain calibration schedules
- Document all calibrations
- Review calibration records
- Address overdue calibrations
Common Finding 7: Supplier Management Gaps
Supplier management gaps include inadequate qualification and lack of monitoring.
How to Prevent:
- Qualify suppliers before use
- Conduct supplier audits
- Monitor supplier performance
- Maintain quality agreements
Common Finding 8: Poor Documentation Practices
Documentation practices include illegible entries and undocumented corrections.
How to Prevent:
- Train personnel on documentation practices
- Implement review processes
- Address documentation errors
- Conduct regular documentation audits
Common Finding 9: Inadequate Change Control
Change control gaps include undocumented changes and incomplete impact assessments.
How to Prevent:
- Implement change control procedures
- Document all changes
- Conduct impact assessments
- Review change control records
Common Finding 10: Facility Maintenance Issues
Facility issues include inadequate cleaning and maintenance.
How to Prevent:
- Implement cleaning and maintenance schedules
- Document all cleaning and maintenance
- Conduct regular facility inspections
- Address facility issues promptly
How GxP Cellators Helps Address Common Findings
GxP Cellators provides GMP audits that identify common findings and recommend corrective actions.
Our GMP Audit Services Include:
- Full scope GMP audits
- Data integrity audits
- Documentation audits
- Deviation investigation audits
- CAPA audits
- Training audits
- Equipment calibration audits
- Supplier audits
- Mock inspections
- CAPA verification and follow up
Why Choose GxP Cellators:
- Auditors with regulatory inspection and industry quality experience
- Coverage of FDA, EMA, Health Canada, MHRA, and WHO requirements
- Risk based approach tailored to your operations
- Practical, actionable reports
- Full confidentiality for your proprietary systems
Frequently Asked Questions
Q1: What are the most common findings in pharmaceutical GMP audits?
The most common findings include data integrity issues, incomplete documentation, inadequate deviation investigation, ineffective CAPA, inadequate training, equipment calibration issues, supplier management gaps, poor documentation practices, inadequate change control, and facility maintenance issues.
Q2: How can data integrity findings be prevented?
Data integrity findings can be prevented by enabling audit trails, eliminating shared accounts, implementing access controls, and training personnel.
Q3: How can deviation investigation findings be prevented?
Deviation investigation findings can be prevented by improving root cause analysis training, implementing CAPA effectiveness checks, and reviewing investigation quality.
Q4: How does GxP Cellators help address common GMP findings?
GxP Cellators provides GMP audits that identify common findings and recommend corrective actions.
Q5: How do I contact GxP Cellators for GMP audit support?
You can reach us through our contact page at https://www.gxpcellators.com/contact/ to discuss your GMP audit requirements.
Contact GxP Cellators
If you need support addressing common GMP audit findings, please contact GxP Cellators.
